Enterome nabs $52.6m
Enterome, a clinical-stage biopharmaceutical company, has raised $52.6 million in funding.
Enterome, a clinical-stage biopharmaceutical company, has raised $52.6 million in funding.
Copyright PEI Media
Not for publication, email or dissemination